1887

Abstract

Virus-specific cytotoxic T lymphocytes (CTLs) are considered to be important in protection against and recovery from viral infections. In this study, several approaches to induce cytotoxicity against bovine herpesvirus 1 (BHV-1) were evaluated. Vaccination of C57BL/6 mice with BHV-1 induced a strong humoral, but no CTL, response, which may be due to downregulation of major histocompatibility complex class I molecules. In contrast, vaccinia virus expressing glycoprotein B (gB) elicited a weaker antibody response, but strong cytotoxicity, in mice. As an approach to inducing both strong humoral and cellular immune responses, a plasmid vector was then used to express gB. Both antibody and CTL responses were induced by the plasmid encoding gB in C57BL/6 and C3H mice, regardless of the type of vector backbone. This demonstrated that DNA immunization induces a broad-based immune response to BHV-1 gB. Interestingly, removal of the membrane anchor, which resulted in secretion of gB from transfected cells, did not result in reduced cytotoxicity. Here, it is shown that, compared with the cell-associated counterpart, plasmid-encoded secreted protein may induce enhanced immune responses in cattle. Therefore, calves were immunized intradermally with pMASIAtgB, a plasmid encoding the secreted form of gB (tgB), using a needle-free injection system. This demonstrated that pMASIAtgB elicited both humoral responses and activated gamma interferon-secreting CD8 CTLs, suggesting that a DNA vaccine expressing tgB induces a CTL response in the natural host of BHV-1.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80533-0
2005-04-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/4/vir860887.html?itemId=/content/journal/jgv/10.1099/vir.0.80533-0&mimeType=html&fmt=ahah

References

  1. Baca-Estrada, M. E., Snider, M., Tikoo, S. K., Harland, R., Babiuk, L. A. & van Drunen Littel-van den Hurk, S. ( 1996; ). Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol 9, 11–22.[CrossRef]
    [Google Scholar]
  2. Badovinac, V. P. & Harty, J. T. ( 2000; ). Intracellular staining for TNF and IFN-γ detects different frequencies of antigen-specific CD8+ T cells. J Immunol Methods 238, 107–117.[CrossRef]
    [Google Scholar]
  3. Bangham, C. R. M. & McMichael, A. J. ( 1990; ). HIV infection. Why the long latent period? Nature 348, 388.[CrossRef]
    [Google Scholar]
  4. Bevan, M. J. ( 1989; ). Immunology. Stimulating killer cells. Nature 342, 478–479.[CrossRef]
    [Google Scholar]
  5. Braun, R., Babiuk, L. A. & van Drunen Littel-van den Hurk, S. ( 1997; ). Enhanced immune response to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD. Vaccine Res 6, 151–164.
    [Google Scholar]
  6. Butz, E. A. & Bevan, M. J. ( 1998; ). Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8, 167–175.[CrossRef]
    [Google Scholar]
  7. Byrne, K. M., Horohov, D. W. & Kousoulas, K. G. ( 1995; ). Glycoprotein B of bovine herpesvirus-1 binds heparin. Virology 209, 230–235.[CrossRef]
    [Google Scholar]
  8. Chan, S. S. M., McConnell, I. & Blacklaws, B. A. ( 2002; ). Generation and characterization of ovine dendritic cells derived from peripheral blood monocytes. Immunology 107, 366–372.[CrossRef]
    [Google Scholar]
  9. Corr, M., Lee, D. J., Carson, D. A. & Tighe, H. ( 1996; ). Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184, 1555–1560.[CrossRef]
    [Google Scholar]
  10. Deshpande, M. S., Ambagala, T. C., Hegde, N. R., Hariharan, M. J., Navaratnam, M. & Srikumaran, S. ( 2002; ). Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 20, 3744–3751.[CrossRef]
    [Google Scholar]
  11. Doe, B., Selby, M., Barnett, S., Baenziger, J. & Walker, C. M. ( 1996; ). Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci U S A 93, 8578–8583.[CrossRef]
    [Google Scholar]
  12. Doherty, P. C. ( 1998; ). Update: the numbers game for virus-specific CD8+ T cells. Science 280, 227.[CrossRef]
    [Google Scholar]
  13. Eskra, L. & Splitter, G. A. ( 1997; ). Bovine herpesvirus-1 infects activated CD4+ lymphocytes. J Gen Virol 78, 2159–2166.
    [Google Scholar]
  14. Fitzpatrick, D. R., Redmond, M. J., Attah-Poku, S. K., van Drunen Littel-van den Hurk, S., Babiuk, L. A. & Zamb, T. J. ( 1990; ). Mapping of 10 epitopes on bovine herpesvirus type 1 glycoproteins gI and gIII. Virology 176, 145–157.[CrossRef]
    [Google Scholar]
  15. Franco, M. A., Lefevre, P., Willems, P., Tosser, G., Lintermanns, P. & Cohen, J. ( 1994; ). Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins. J Gen Virol 75, 589–596.[CrossRef]
    [Google Scholar]
  16. Fu, T. M., Ulmer, J. B., Caulfield, M. J., Deck, R. R., Friedman, A., Wang, S., Liu, X., Donnelly, J. J. & Liu, M. A. ( 1997; ). Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 3, 362–371.
    [Google Scholar]
  17. Fuller, A. O. & Lee, W.-C. ( 1992; ). Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J Virol 66, 5002–5012.
    [Google Scholar]
  18. Griebel, P. J., Ohmann, H. B., Lawman, M. J. P. & Babiuk, L. A. ( 1990; ). The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J Gen Virol 71, 369–377.[CrossRef]
    [Google Scholar]
  19. Hariharan, M. J., Nataraj, C. & Srikumaran, S. ( 1993; ). Down regulation of murine MHC class I expression by bovine herpesvirus 1. Viral Immunol 6, 273–284.[CrossRef]
    [Google Scholar]
  20. Iwasaki, A., Stiernholm, B. J., Chan, A. K., Berinstein, N. L. & Barber, B. H. ( 1997; ). Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158, 4591–4601.
    [Google Scholar]
  21. Kostense, S., Ogg, G. S., Manting, E. H. & 8 other authors ( 2001; ). High viral burden in the presence of major HIV-specific CD8+ T cell expansions: evidence for impaired CTL effector function. Eur J Immunol 31, 677–686.[CrossRef]
    [Google Scholar]
  22. Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D. & Davis, H. L. ( 1998; ). Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A 95, 12631–12636.[CrossRef]
    [Google Scholar]
  23. Kühn, J. E., Kramer, M. D., Willenbacher, W., Wieland, U., Lorentzen, E. U. & Braun, R. W. ( 1990; ). Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface. J Virol 64, 2491–2497.
    [Google Scholar]
  24. Lewis, P. J., van Drunen Littel-van den Hurk, S. & Babiuk, L. A. ( 1999; ). Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol 73, 10214–10223.
    [Google Scholar]
  25. Li, Y., van Drunen Littel-van den Hurk, S., Liang, X. & Babiuk, L. A. ( 1996; ). Production and characterization of bovine herpesvirus 1 glycoprotein B ectodomain derivatives in an hsp70A gene promoter-based expression system. Arch Virol 141, 2019–2029.[CrossRef]
    [Google Scholar]
  26. Li, Y., van Drunen Littel-van den Hurk, S., Liang, X. & Babiuk, L. A. ( 1997; ). Functional analysis of the transmembrane anchor region of bovine herpesvirus 1 glycoprotein gB. Virology 228, 39–54.[CrossRef]
    [Google Scholar]
  27. Madin, S. H., York, C. J. & McKercher, D. G. ( 1956; ). Isolation of the infectious bovine rhinotracheitis virus. Science 124, 721–722.[CrossRef]
    [Google Scholar]
  28. Miethke, A., Keil, G. M., Weiland, F. & Mettenleiter, T. C. ( 1995; ). Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J Gen Virol 76, 1623–1635.[CrossRef]
    [Google Scholar]
  29. Mikloska, Z. & Cunningham, A. L. ( 1998; ). Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J Gen Virol 79, 353–361.
    [Google Scholar]
  30. Misra, V., Blumenthal, R. M. & Babiuk, L. A. ( 1981; ). Proteins specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J Virol 40, 367–378.
    [Google Scholar]
  31. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J. & Ahmed, R. ( 1998; ). Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187.[CrossRef]
    [Google Scholar]
  32. Nataraj, C., Eidmann, S., Hariharan, M. J., Sur, J. H., Perry, G. A. & Srikumaran, S. ( 1997; ). Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral Immunol 10, 21–34.[CrossRef]
    [Google Scholar]
  33. Paliard, X., Doe, B., Selby, M. J., Hartog, K., Lee, A. Y., Burke, R. L. & Walker, C. M. ( 2001; ). Induction of herpes simplex virus gB-specific cytotoxic T lymphocytes in TAP1-deficient mice by genetic immunization but not HSV infection. Virology 282, 56–64.[CrossRef]
    [Google Scholar]
  34. Pontarollo, R. A., Babiuk, L. A., Hecker, R. & van Drunen Littel-van den Hurk, S. ( 2002; ). Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 83, 2973–2981.
    [Google Scholar]
  35. Raggo, C., Habermehl, M., Babiuk, L. A. & Griebel, P. ( 2000; ). The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-γ. J Gen Virol 81, 2665–2673.
    [Google Scholar]
  36. Smith, P. M., Zhang, Y., Jennings, S. R. & O'Callaghan, D. J. ( 1998; ). Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice. J Virol 72, 5366–5372.
    [Google Scholar]
  37. Torres, C. A., Iwasaki, A., Barber, B. H. & Robinson, H. L. ( 1997; ). Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 158, 4529–4532.
    [Google Scholar]
  38. Townsend, A. R. M., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D. & McMichael, A. J. ( 1986; ). The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959–968.[CrossRef]
    [Google Scholar]
  39. Truong, M.-J., Darcissac, E. C. A., Hermann, E., Dewulf, J., Capron, A. & Bahr, G. M. ( 1999; ). Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells. J Virol 73, 7008–7013.
    [Google Scholar]
  40. Ulmer, J. B., Deck, R. R., DeWitt, C. M., Donnelly, J. J. & Liu, M. A. ( 1996; ). Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89, 59–67.[CrossRef]
    [Google Scholar]
  41. van Drunen Littel-van den Hurk, S., van den Hurk, J. V., Gilchrist, J. E., Misra, V. & Babiuk, L. A. ( 1984; ). Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135, 466–479.[CrossRef]
    [Google Scholar]
  42. van Drunen Littel-van den Hurk, S., van den Hurk, J. V. & Babiuk, L. A. ( 1985; ). Topographical analysis of bovine herpesvirus type-1 glycoproteins: use of monoclonal antibodies to identify and characterize functional epitopes. Virology 144, 216–227.[CrossRef]
    [Google Scholar]
  43. van Drunen Littel-van den Hurk, S., Zamb, T. & Babiuk, L. A. ( 1989; ). Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virus. J Virol 63, 2159–2168.
    [Google Scholar]
  44. van Drunen Littel-van den Hurk, S., Gifford, G. A. & Babiuk, L. A. ( 1990; ). Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8, 358–368.[CrossRef]
    [Google Scholar]
  45. van Drunen Littel-van den Hurk, S., Braun, R. P., Lewis, P. J., Karvonen, B. C., Baca-Estrada, M. E., Snider, M., McCartney, D., Watts, T. & Babiuk, L. A. ( 1998; ). Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J Gen Virol 79, 831–839.
    [Google Scholar]
  46. Vasilakos, J. P. & Michael, J. G. ( 1993; ). Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells. J Immunol 150, 2346–2355.
    [Google Scholar]
  47. Whetstone, C. A., Miller, J. M., Seal, B. S., Bello, L. J. & Lawrence, W. C. ( 1992; ). Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch Virol 122, 207–214.[CrossRef]
    [Google Scholar]
  48. Witmer, L. A., Rosenthal, K. L., Graham, F. L., Friedman, H. M., Yee, A. & Johnson, D. C. ( 1990; ). Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins. J Gen Virol 71, 387–396.[CrossRef]
    [Google Scholar]
  49. Wyler, R., Engels, M. & Schwyzer, M. ( 1989; ). Infectious bovine rhinotracheitis/vulvovaginitis (BHV1). In Herpesvirus Diseases of Cattle, Horses, and Pigs, pp. 1–72. Edited by G. Wittmann. Boston: Kluwer.
  50. Yates, W. D. G. ( 1982; ). A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral–bacterial synergism in respiratory disease of cattle. Can J Comp Med 46, 225–263.
    [Google Scholar]
  51. Zatechka, D. S., Jr, Hegde, N. R., Hariharan, K. & Srikumaran, S. ( 1999; ). Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1. Vaccine 17, 686–694.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80533-0
Loading
/content/journal/jgv/10.1099/vir.0.80533-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error